Screener
InMed Pharmaceuticals INM Q4 2025 earnings
Reported February 11, 2026 · After market close
Revenue$1.1M
EPS-$0.51
Next report
Sep 23, 2026 (In 5 days)Revenue estimate$2.1B
EPS estimate-$94.44
Versus estimates
Diluted EPS
FAQ
- When did InMed Pharmaceuticals report Q4 2025 earnings?
- InMed Pharmaceuticals (INM) reported Q4 2025 earnings on February 11, 2026 after market close.
- What were InMed Pharmaceuticals's Q4 2025 revenue and EPS?
- InMed Pharmaceuticals reported revenue of $1.1M and eps of $-0.51 for Q4 2025.
- How did InMed Pharmaceuticals's Q4 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue declined 99.9% from $772.5M a year earlier and eps grew 86.0% from $-3.64.
- Where can I find InMed Pharmaceuticals's Q4 2025 SEC filings?
- You can read the 8-K earnings release (0001062993-26-000819) and the 10-Q periodic report (0001213900-26-014996) directly on SEC EDGAR. The filing index links above go to sec.gov.
